US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

US IPOs and Secondary Offerings

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

IPOs and Secondary Offerings

Equity Capital Markets

Lumexa Imaging Holdings / Equity Capital Markets

<ul>
<li>Lumexa advances its IPO with a 25M-share offering, targeting a $1.6–$1.9B valuation and expecting over $427M in primary proceeds.</li>
<li>As the second-largest U.S. outpatient imaging provider, the company operates 184 centers with strong referral networks, high-growth markets, and leadership in advanced imaging.</li>
<li>Revenue growth remains steady and diversified across modalities, supporting a stable sector profile and an attractive risk-reward setup backed by a strong underwriting syndicate.</li>
</ul>


Lumexa advances its IPO with a 25M-share offering, targeting a $1.6–$1.9B valuation and expecting over $427M in primary proceeds.
As the second-largest U.S. outpatient imaging provider, the company operates 184 centers with strong referral networks, high-growth markets, and leadership in advanced imaging.
Revenue growth remains steady and diversified across modalities, supporting a stable sector profile and an attractive risk-reward setup backed by a strong underwriting syndicate.


Lumexa Imaging Holdings, Inc. (LMRI): Diagnostic Imaging Service Seeking up to $1.9b Valuation

<ul>
<li>Lumexa Imaging, one of the nation’s largest outpatient imaging providers, could join the limited group of IPOs expected to debut in December 2025.</li>
<li>The company operates 184 centers across 13 states, benefiting from strong population growth markets and a broad, diversified referring-physician network.</li>
<li>Backed by WCAS and supported by scalable technology and growing advanced imaging demand, Lumexa shows steady revenue momentum ahead of a potential year-end IPO.</li>
</ul>


Lumexa Imaging, one of the nation’s largest outpatient imaging providers, could join the limited group of IPOs expected to debut in December 2025.
The company operates 184 centers across 13 states, benefiting from strong population growth markets and a broad, diversified referring-physician network.
Backed by WCAS and supported by scalable technology and growing advanced imaging demand, Lumexa shows steady revenue momentum ahead of a potential year-end IPO.


Lumexa Imaging Holdings, Inc. (LMRI): Peeking at the IPO Prospectus of a Diagnostic Imaging Service

United States

Lumexa Imaging Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical diagnostic imaging services including X-rays, MRI, CT scans, and mammogram. Lumexa Imaging serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Lumexa Imaging Holdings (LMRI US)

Lumexa Imaging Holdings, Inc. (LMRI): Diagnostic Imaging Service Seeking up to $1.9b Valuation

Lumexa prepares for IPO with strong revenue growth and leadership in advanced imaging, targeting $1.6–$1.9B valuation and $427M in proceeds.

IPO Boutique

Lumexa Imaging Holdings, Inc. (LMRI): Peeking at the IPO Prospectus of a Diagnostic Imaging Service

Lumexa Imaging is poised for a potential IPO in December 2025 with strong revenue momentum and broad network of centers.

IPO Boutique

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Lumexa Imaging Holdings, Inc. (LMRI): Diagnostic Imaging Service Seeking up to $1.9b Valuation

​Lumexa prepares for IPO with strong revenue growth and leadership in advanced imaging, targeting $1.6–$1.9B valuation and $427M in proceeds.

IPO Boutique

Lumexa Imaging Holdings, Inc. (LMRI): Peeking at the IPO Prospectus of a Diagnostic Imaging Service

​Lumexa Imaging is poised for a potential IPO in December 2025 with strong revenue momentum and broad network of centers.

IPO Boutique

Lumexa prepares for IPO with strong revenue growth and leadership in advanced imaging, targeting $1.6–$1.9B valuation and $427M in proceeds.

Lumexa Imaging is poised for a potential IPO in December 2025 with strong revenue momentum and broad network of centers.